ArticleOncology reports2018

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.

Jianlin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.